|
ZNF35 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.14009998611431E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.10170000292109E-08 |
| Normal-vs-Stage2 |
2.111800E-02 |
| Normal-vs-Stage3 |
1.14720000166102E-08 |
| Normal-vs-Stage4 |
5.29220000045072E-08 |
| Stage1-vs-Stage2 |
1.807780E-02 |
| Stage1-vs-Stage3 |
1.026630E-01 |
| Stage1-vs-Stage4 |
4.052000E-02 |
| Stage2-vs-Stage3 |
1.900390E-03 |
| Stage2-vs-Stage4 |
8.248100E-04 |
| Stage3-vs-Stage4 |
4.865200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.36749997384322E-09 |
| Normal-vs-AfricanAmerican |
2.944500E-03 |
| Normal-vs-Asian |
2.0187999999921E-05 |
| Caucasian-vs-AfricanAmerican |
6.799000E-01 |
| Caucasian-vs-Asian |
9.382600E-01 |
| AfricanAmerican-vs-Asian |
7.556800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.89200000003209E-06 |
| Normal-vs-Female |
9.26890009189663E-10 |
| Male-vs-Female |
6.949800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.99679999599323E-08 |
| Normal-vs-Age(41-60Yrs) |
4.72410000007528E-09 |
| Normal-vs-Age(61-80Yrs) |
1.9894999999992E-05 |
| Normal-vs-Age(81-100Yrs) |
1.447590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.646800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.465200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.082400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.761950E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.739600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.627000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.044300E-03 |
| Classical-VS-Follicular |
1.223830E-01 |
| Classical-VS-Other |
3.839200E-01 |
| Classical-VS-Normal |
2.31810000084209E-08 |
| Tall-VS-Follicular |
7.778700E-04 |
| Tall-VS-Other |
6.074800E-01 |
| Tall-VS-Normal |
2.14480000426676E-08 |
| Follicular-VS-Other |
1.773000E-01 |
| Follicular-VS-Normal |
3.031400E-04 |
| Other-VS-Normal |
6.141000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.94789999971879E-07 |
| Normal-vs-N1 |
2.57579999995983E-06 |
| N0-vs-N1 |
2.382200E-01 |
|
|
